These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

924 related articles for article (PubMed ID: 21095413)

  • 1. Male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH).
    Roehrborn CG
    Med Clin North Am; 2011 Jan; 95(1):87-100. PubMed ID: 21095413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Initial assessment, follow-up and treatment of lower urinary tract symptoms related to benign prostatic hyperplasia: guidelines of the LUTS committee of the French Urological Association].
    Descazeaud A; Robert G; Delongchamps NB; Cornu JN; Saussine C; Haillot O; Devonec M; Fourmarier M; Ballereau C; Lukacs B; Dumonceau O; Azzouzi AR; Faix A; Desgrandchamps F; de la Taille A;
    Prog Urol; 2012 Dec; 22(16):977-88. PubMed ID: 23178093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benign prostatic hyperplasia - progress in pathophysiology and management.
    Dobrek Ł; Thor PJ
    Pol Merkur Lekarski; 2015 Nov; 39(233):263-70. PubMed ID: 26637089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of combination medical therapy in benign prostatic hyperplasia.
    Greco KA; McVary KT
    Int J Impot Res; 2008 Dec; 20 Suppl 3():S33-43. PubMed ID: 19002123
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benign Prostatic Hyperplasia.
    Langan RC
    Prim Care; 2019 Jun; 46(2):223-232. PubMed ID: 31030823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current medical treatment of lower urinary tract symptoms/BPH: do we have a standard?
    Silva J; Silva CM; Cruz F
    Curr Opin Urol; 2014 Jan; 24(1):21-8. PubMed ID: 24231531
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Management of Benign Prostatic Hyperplasia in Older Adults.
    Woodard TJ; Manigault KR; McBurrows NN; Wray TL; Woodard LM
    Consult Pharm; 2016; 31(8):412-24. PubMed ID: 27535076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of benign prostatic hyperplasia.
    Pinheiro LC; Martins Pisco J
    Tech Vasc Interv Radiol; 2012 Dec; 15(4):256-60. PubMed ID: 23244720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacological treatment of benign prostatic hyperplasia].
    Oelke M; Martinelli E
    Urologe A; 2016 Jan; 55(1):81-94; quiz 95-6. PubMed ID: 26676726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign prostatic hyperplasia and lower urinary tract symptoms: evidence and approaches for best case management.
    Barkin J
    Can J Urol; 2011 Apr; 18 Suppl():14-9. PubMed ID: 21501546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical treatment of lower urinary tract symptoms/benign prostatic hyperplasia: anything new in 2015.
    Schauer I; Madersbacher S
    Curr Opin Urol; 2015 Jan; 25(1):6-11. PubMed ID: 25393269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An algorithm for medical management in male lower urinary tract symptoms.
    Djavan B; Margreiter M; Dianat SS
    Curr Opin Urol; 2011 Jan; 21(1):5-12. PubMed ID: 21045704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severity of lower urinary tract symptoms reflects different composition of bladder storage dysfunction and bladder outlet obstruction in men with symptomatic benign prostatic hyperplasia.
    Jhang JF; Liao CH; Kuo HC
    Int J Clin Pract; 2014 Jun; 68(6):743-8. PubMed ID: 24471413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction.
    Oelke M; Bachmann A; Descazeaud A; Emberton M; Gravas S; Michel MC; N'dow J; Nordling J; de la Rosette JJ;
    Eur Urol; 2013 Jul; 64(1):118-40. PubMed ID: 23541338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Guide dedicated to general practitioner for the management of lower urinary tract symptoms related to benign prostatic hyperplasia].
    Descazeaud A; Barry Delongchamps N; Cornu JN; Azzouzi AR; Buchon D; Benchikh A; Coloby P; Dumonceau O; Fourmarier M; Haillot O; Lebdai S; Mathieu R; Misrai V; Saussine C; de La Taille A; Robert G;
    Prog Urol; 2015 Jun; 25(7):404-12. PubMed ID: 25841758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medical therapy for benign prostatic hyperplasia: a review.
    Van Asseldonk B; Barkin J; Elterman DS
    Can J Urol; 2015 Oct; 22 Suppl 1():7-17. PubMed ID: 26497339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urological disorders in men: urinary incontinence and benign prostatic hyperplasia.
    Miller SW; Miller MS
    J Pharm Pract; 2011 Aug; 24(4):374-85. PubMed ID: 21984774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Change in International Prostate Symptom storage subscore after long-term medical therapy in BPH patients: finasteride and alpha-blocker combination therapy in men with moderate-to-severe LUTS/BPH in Korea.
    Lee JY; Lee SH; Kim SJ; Kim CS; Lee HM; Kim CI; Chung BH
    Urology; 2011 Jan; 77(1):171-6. PubMed ID: 20691464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation and medical management of benign prostatic hyperplasia.
    Beckman TJ; Mynderse LA
    Mayo Clin Proc; 2005 Oct; 80(10):1356-62. PubMed ID: 16212149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of Benign Prostatic Hyperplasia.
    Kim EH; Larson JA; Andriole GL
    Annu Rev Med; 2016; 67():137-51. PubMed ID: 26331999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 47.